Sanofi-Genzyme BioVentures (SGBV) is different from traditional venture capital firms: we only invest in early-stage life science companies developing innovative products that may become future Sanofi products. We also back our financial support with world class technical and strategic guidance through access to the Sanofi and Genzyme teams.
SGBV is the corporate venture capital arm of Sanofi. Previously known as Genzyme Ventures, SGBV has a recently expanded mandate to invest across the more expansive businesses of Sanofi.
The SGBV team is based in Cambridge, Mass., and invests all over the world.
Learn more on the Sanofi-Genzyme Bioventures website.
Partnering with Genzyme
Collaboration drives our external partnerships, where we seek complementary strengths that can help us bring groundbreaking new products to market.
Learn more about partnering
Last Updated: 5/13/2015